VISTAGEN THERAPEUTICS INC (VTGN) Earnings History & Surprises
NASDAQ:VTGN • US92840H4002
0.6077 USD
-0.01 (-1.07%)
At close: Mar 6, 2026
0.6183 USD
+0.01 (+1.74%)
After Hours: 3/6/2026, 8:00:02 PM
Past quarterly earnings results for VISTAGEN THERAPEUTICS INC (VTGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateJun 15, 2026
PeriodQ4 / 2026
EPS Estimate-$0.34
Revenue Estimate273.023K
Last Reported
Release DateFeb 12, 2026
PeriodQ3 / 2026
EPS Reported-$0.45
EPS Surprise 9.22%
Revenue Surprise -18.84%
Beat Rate
50%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | -0.45 | -0.50 | 9.22% | 2.17% | 303K | 373.32K | -18.84% | 29.49% |
| Q2 2026 | -0.54 | -0.49 | -11.22% | -28.57% | 258K | 248.197K | 3.95% | 40.98% |
| Q1 2026 | -0.47 | -0.48 | 2.65% | -34.29% | 244K | 663K | -63.20% | 190.48% |
| Q4 2025 | -0.43 | -0.51 | 14.73% | -72.80% | 15K | 321.3K | -95.33% | -92.39% |
| Q3 2025 | -0.46 | -0.52 | 11.57% | -109.09% | 234K | 183.6K | 27.45% | -43.12% |
| Q2 2025 | -0.42 | -0.40 | -5.58% | 36.36% | 183K | 227.797K | -19.67% | -34.10% |
| Q1 2025 | -0.35 | -0.41 | 15.27% | -1,043.79% | 84K | 306K | -72.55% | -53.33% |
| Q4 2024 | -0.25 | -0.37 | 32.39% | 85.71% | 197K | 206.805K | -4.74% | 12.19% |
| Q3 2024 | -0.22 | -0.31 | 28.70% | 85.33% | 411.4K | 555.39K | -25.93% | 128.56% |
| Q2 2024 | -0.66 | -0.69 | 4.84% | 72.50% | 277.7K | 181.56K | 52.95% | 131.20% |
| Q1 2024 | -0.03 | - | 98.98% | 180K | 188.7K | -4.61% | -41.94% | |
| Q4 2023 | -1.75 | -1.53 | -14.38% | 35.19% | 175.6K | - | 339.00% | |
| Q3 2023 | -1.50 | -2.14 | 29.97% | - | 180K | 158.1K | 13.85% | -50.00% |
| Q2 2023 | -2.40 | -2.04 | -17.64% | -14.29% | -890K | 316.2K | -381.47% | -347.22% |
| Q1 2023 | -3.00 | -2.30 | -30.72% | -150.00% | 310K | 345.27K | -10.22% | -11.43% |
| Q4 2022 | -2.70 | -1.76 | -53.45% | 55.00% | 40K | 359.723K | -88.88% | -90.91% |
| Q3 2022 | -1.50 | -2.22 | 32.39% | 28.57% | 360K | 259.08K | 38.95% | 16.13% |
| Q2 2022 | -2.10 | -1.76 | -19.35% | -40.00% | 360K | 268.77K | 33.94% | 9.09% |
| Q1 2022 | -1.20 | -1.63 | 26.47% | 42.86% | 350K | 388.283K | -9.86% | - |
| Q4 2021 | -6.00 | -1.53 | -292.16% | -185.71% | 440K | 233.07K | 88.78% | - |
| Q3 2021 | -2.10 | -1.63 | -28.68% | 53.33% | 310K | 215.557K | 43.81% | - |
| Q2 2021 | -1.50 | -0.71 | -110.11% | 61.54% | 330K | 1.7M | -80.59% | - |
| Q1 2021 | -2.10 | -3.83 | 45.10% | 53.33% | - | - | ||
| Q4 2020 | -2.10 | -2.45 | 14.22% | - | - | - | ||
| Q3 2020 | -4.50 | -2.14 | -110.08% | - | - | - | ||
| Q2 2020 | -3.90 | -4.13 | 5.59% | - | - | - | ||
| Q1 2020 | -4.50 | -3.37 | -33.69% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
3.84%
Max EPS beat (4)
14.73%
Min EPS beat (4)
-11.22%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-43.35%
Max Revenue beat (4)
3.95%
Min Revenue beat (4)
-95.33%
Analysis
In the last 4 quarters, VTGN has beaten EPS estimates in 3 out of 4 releases
VTGN has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, VTGN has beaten the EPS estimates by 3.8% on average.
In the last 4 quarters, VTGN reported -43.4% below the revenue estimates on average.
VISTAGEN THERAPEUTICS INC / VTGN Earnings FAQ
What is the most recent earnings date for VTGN stock?
VISTAGEN THERAPEUTICS INC (VTGN) last reported earnings on 2/12/2026.
Did VTGN stock beat earnings estimates in the most recent quarter?
VISTAGEN THERAPEUTICS INC (VTGN) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often VISTAGEN THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, VISTAGEN THERAPEUTICS INC (VTGN) has beaten EPS estimates in 3 out of 4 releases.